Apigenin (4',5,7-Trihydroxyflavone) is identified as a competitive CYP2C9 inhibitor with a Ki of 2 μM. It demonstrates the ability to inhibit cell proliferation, with growth inhibition rates of 38%, 71%, and 99% at concentrations of 20, 40, and 80 μM respectively. The compound also suppresses clone formation in SGC-7901 cells in a dose- and time-dependent manner.
- Competitive inhibitor of Cytochrome P450 2C9 (CYP2C9).
- Exhibits cell proliferation inhibitory activity.
- Suppresses clone formation in specific cell lines.